多模态影像在指导胰腺神经内分泌肿瘤可切除性与减瘤术中的作用:聚焦PET与MRI
本文综述胰腺神经内分泌肿瘤(pNETs)的多模态影像应用,包括定位肿瘤、评估范围及判断根治性手术或减瘤术的可行性。pNETs在CT、MRI和PET上表现独特,68Ga生长抑素受体(SSTR)PET对高分化pNETs敏感,18F-FDG PET对侵袭性低分化pNETs敏感。全面解读多模态影像可指导可切除性与减瘤术,影像表型提供分化、增殖及肿瘤时空异质性信息,具有预后和治疗意义。
要点
- 68Ga-SSTR PET对高分化pNETs检测敏感,18F-FDG PET对更具侵袭性的低分化pNETs敏感。
- 影像表型可提供pNETs分化与增殖信息,以及肿瘤时空异质性,具有预后和治疗意义。
- 多模态影像综合解读用于定位肿瘤、评估范围并判断根治性手术或减瘤术的可行性。
核心结论
- 多模态影像的综合解读可指导pNETs的可切除性与减瘤术,影像表型提供分化、增殖及肿瘤时空异质性信息,具有预后和治疗意义。
研究设计与样本
- 综述,提供聚焦PET与MR技术的标准化阅读与报告的结构化方法。
关键影像表现/征象
- pNETs在CT、MRI和PET上具有非常独特的表型。
- 68Ga-SSTR PET对高分化pNETs检测敏感。
- 18F-FDG PET对更具侵袭性的低分化pNETs检测敏感。
临床应用与阅片要点
- 综述解释不同pNET亚型应使用何种影像方法。
- 综述说明放射科医生在解读这些研究时应寻找和报告的内容。
- 综述提供聚焦PET和MR技术的标准化阅读与报告的结构化方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pancreatic neuroendocrine tumors (pNETs) are rare neoplasms that secrete peptides and neuro-amines. pNETs can be sporadic or hereditary, syndromic or non-syndromic with different clinical presentations and prognoses. The role of medical imaging includes locating the tumor, assessing its extent, and evaluating the feasibility of curative surgery or cytoreduction. Pancreatic NETs have very distinctive phenotypes on CT, MRI, and PET. PET have been demonstrated to be very sensitive to detect either well-differentiated pNETs using 68Gallium somatostatin receptor (SSTR) radiotracers, or more aggressive undifferentiated pNETS using 18F-FDG. A comprehensive interpretation of multimodal imaging guides resectability and cytoreduction in pNETs. The imaging phenotype provides information on the differentiation and proliferation of pNETs, as well as the spatial and temporal heterogeneity of tumors with prognostic and therapeutic implications. This review provides a structured approach for standardized reading and reporting of medical imaging studies with a focus on PET and MR techniques. It explains which imaging approach should be used for different subtypes of pNET and what a radiologist should be looking for and reporting when interpreting these studies.
引用
- Rozenblum L, Mokrane FZ, Yeh R, et al. The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI. Abdom Radiol (NY). 2019. PMID: 30980115. doi:10.1007/s00261-019-01994-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。